Literature DB >> 24069507

Transgenic mammary epithelial osteopontin (spp1) expression induces proliferation and alveologenesis.

Neil E Hubbard1, Qian J Chen, Laura K Sickafoose, Meghan B Wood, Jeffrey P Gregg, Ninnie M Abrahamsson, Jesse A Engelberg, Judith E Walls, Alexander D Borowsky.   

Abstract

Osteopontin (OPN) Spp1 is involved in differentiation of the mammary gland. We engineered mice to overexpress OPN in mammary epithelium and describe an altered mammary phenotype. Three transgenic (Tg) founder lines FVB/N Tg(MMTV-Opn)((1-3BOR)) were propagated after FVB/NJ pronuclear injections. Mammary glands from Tg-OPN mice compared to littermate controls showed, at 4 weeks of age, exaggerated terminal end buds; at 8 and 12 weeks, more numerous and complex ducts with increased luminal protein; and at 16 weeks, increased lobulogenesis. Lactational Tg-OPN mammary glands showed more rapid lobulogenesis and lactational changes with slower gland involution and regression following weaning. Ex vivo lobulogenesis was noticeably increased from organoids of Tg-OPN mice. Immunohistochemistry revealed cytoplasmic OPN accumulation and increased Ki-67 positive mammary epithelial cells in Tg-OPN mammary glands. OPN appears to convey a proliferative stimulus for mammary epithelial cells and alters development and differentiation. These OPN mammary overexpressing mice provide a means to study the role of OPN in cancer progression.

Entities:  

Keywords:  flow cytometry; involution; lobulogenesis; mammary gland; organoid culture; osteopontin

Year:  2013        PMID: 24069507      PMCID: PMC3782008          DOI: 10.1177/1947601913496813

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  29 in total

1.  Osteopontin expression in mammary gland development and tumorigenesis.

Authors:  S R Rittling; K E Novick
Journal:  Cell Growth Differ       Date:  1997-10

2.  BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms.

Authors:  Arnaud A Mailleux; Michael Overholtzer; Tobias Schmelzle; Philippe Bouillet; Andreas Strasser; Joan S Brugge
Journal:  Dev Cell       Date:  2007-02       Impact factor: 12.270

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 4.  Anatomy of the human mammary gland: Current status of knowledge.

Authors:  Foteini Hassiotou; Donna Geddes
Journal:  Clin Anat       Date:  2012-09-19       Impact factor: 2.414

5.  Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency.

Authors:  M Nemir; D Bhattacharyya; X Li; K Singh; A B Mukherjee; B B Mukherjee
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

6.  Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells.

Authors:  Mohamed K El-Tanani; Hiu-Fung Yuen; Zhanzhong Shi; Angela Platt-Higgins; Niamh E Buckley; Paul B Mullan; Denis Paul Harkin; Patrick G Johnston; Philip S Rudland
Journal:  Cancer Sci       Date:  2010-03-10       Impact factor: 6.716

Review 7.  The role of osteopontin in breast cancer: clinical and experimental studies.

Authors:  A B Tuck; A F Chambers
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

8.  EMT tumorigenesis in the mouse mammary gland.

Authors:  Patrizia Damonte; Jeffrey P Gregg; Alexander D Borowsky; Blaine A Keister; Robert D Cardiff
Journal:  Lab Invest       Date:  2007-10-08       Impact factor: 5.662

Review 9.  Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Mol Med       Date:  2010-07-01       Impact factor: 5.310

10.  Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin.

Authors:  Katayoun Alavi Jessen; Stephenie Y Liu; Clifford G Tepper; Juliana Karrim; Erik T McGoldrick; Andrea Rosner; Robert J Munn; Lawrence J T Young; Alexander D Borowsky; Robert D Cardiff; Jeffrey P Gregg
Journal:  Breast Cancer Res       Date:  2004-02-25       Impact factor: 6.466

View more
  7 in total

1.  An Integrative Single-cell Transcriptomic Atlas of the Post-natal Mouse Mammary Gland Allows Discovery of New Developmental Trajectories in the Luminal Compartment.

Authors:  Martín E García Solá; Micaela Stedile; Inés Beckerman; Edith C Kordon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-04-28       Impact factor: 2.673

2.  Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.

Authors:  Yi He; Ruijie Liu; Mei Yang; Wu Bi; Liuyin Zhou; Sai Zhang; Jin Jin; Xujun Liang; Pengfei Zhang
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

3.  SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma.

Authors:  Weiguo Zhang; Junli Fan; Qiang Chen; Caipeng Lei; Bin Qiao; Qin Liu
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

4.  Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer.

Authors:  Yaqin Tu; Cai Chen; Guorun Fan
Journal:  BMC Cancer       Date:  2019-12-18       Impact factor: 4.430

5.  A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer.

Authors:  Jun Wang; Hua Zheng; Yatian Han; Geng Wang; Yanbin Li
Journal:  Int J Genomics       Date:  2020-12-14       Impact factor: 2.326

6.  Identifying luminal and basal mammary cell specific genes and their expression patterns during pregnancy.

Authors:  Zhan Dong Li; Xiangtian Yu; Zi Mei; Tao Zeng; Lei Chen; Xian Ling Xu; Hao Li; Tao Huang; Yu-Dong Cai
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.752

7.  Hormone-Responsive BMP Signaling Expands Myoepithelial Cell Lineages and Prevents Alveolar Precocity in Mammary Gland.

Authors:  Chunlei Shao; Pengbo Lou; Ruiqi Liu; Xueyun Bi; Guilin Li; Xu Yang; Xiaole Sheng; Jiuzhi Xu; Cong Lv; Zhengquan Yu
Journal:  Front Cell Dev Biol       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.